Biotech: Why It’s Not a Bubble

Barclays’ Geoff Meacham explains why he doesn’t think biotech stocks like Biogen Idec (BIIB) and Gilead Sciences (GILD) are in bubble territory: Bloomberg News Our industry view is still positive; fundamentally, we believe that biotech is still in the early innings of an innovation cycle, but one could argue that valuations (more in SMId than [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.